PHK
VIVO

Point72 Hong Kong’s Meridian Bioscience Inc VIVO Stock Holding History

Point72 Hong Kong’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,812
Closed -$31K – 2133
2020
Q3 		$31K Buy
+1,812
New +$35.2K ﹤0.01% 779
2018
Q2 		– Sell
-2
Closed – – 1273
2018
Q1 		$0 Buy
+2
New +$30 ﹤0.01% 1222

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Hong Kong's VIVO Position: Q4 2020 in Review

Point72 Hong Kong sold out of Meridian Bioscience Inc (VIVO) in Q4 2020, closing a stake of 1,812 shares — an estimated $31K sold.

Point72 Hong Kong first reported a position in VIVO in Q1 2018 and held it in 2 quarters. The position peaked at $31K in Q3 2020. 192 funds tracked by Wall St. Rank hold VIVO as of Q4 2020.

  • Point72 Hong Kong reported no remaining Meridian Bioscience Inc position as of Q4 2020 after selling out during the quarter.
  • Point72 Hong Kong sold 1,812 Meridian Bioscience Inc shares in Q4 2020, an estimated $31K.
  • Point72 Hong Kong first reported a position in Meridian Bioscience Inc in Q1 2018 and held it in 2 quarters.
  • Point72 Hong Kong's Meridian Bioscience Inc position peaked at $31K in Q3 2020.
  • 192 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2020.

Based on Point72 Hong Kong's 13F filing for Q4 2020, filed 16 Feb 2021.